ASTRIA THERAPEUTICS INC's ticker is and the CUSIP is 04635X102. A total of 107 filers reported holding ASTRIA THERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $2,006,138 | -64.2% | 142,532 | -80.5% | 0.79% | -79.1% |
Q4 2023 | $5,606,400 | -44.2% | 730,000 | -45.8% | 3.81% | -27.4% |
Q3 2023 | $10,049,276 | -10.4% | 1,347,088 | 0.0% | 5.24% | -38.3% |
Q2 2023 | $11,221,243 | -37.4% | 1,347,088 | 0.0% | 8.49% | -14.6% |
Q1 2023 | $17,916,270 | -11.2% | 1,347,088 | -0.6% | 9.94% | -3.0% |
Q4 2022 | $20,181,489 | +401.7% | 1,355,372 | +204.6% | 10.26% | +595.3% |
Q3 2022 | $4,023,000 | – | 445,000 | – | 1.48% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Altium Capital Management LP | 1,355,372 | $20,181,489 | 10.26% |
Fairmount Funds Management LLC | 1,901,397 | $28,311,801 | 4.49% |
Tri Locum Partners LP | 651,330 | $9,698,000 | 3.92% |
Vivo Capital, LLC | 1,681,199 | $25,033 | 2.88% |
Ghost Tree Capital, LLC | 450,000 | $6,701,000 | 2.86% |
Affinity Asset Advisors, LLC | 472,482 | $7,035,257 | 2.76% |
Ikarian Capital, LLC | 675,176 | $10,053,370 | 2.42% |
Cormorant Asset Management, LP | 1,650,000 | $24,569 | 1.64% |
Logos Global Management LP | 864,960 | $12,879,254 | 1.51% |
SPHERA FUNDS MANAGEMENT LTD. | 469,340 | $6,988,473 | 1.50% |